CTCX:NSD-Carmell Therapeutics Corporation (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 1.33

Change

+0.11 (+9.02)%

Market Cap

USD 0.02B

Volume

8.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
IPAR Inter Parfums Inc

N/A

USD 3.72B
NWL Newell Brands Inc

N/A

USD 2.78B
HELE Helen of Troy Ltd

N/A

USD 2.12B
EWCZ European Wax Center Inc

N/A

USD 0.65B
WALD Waldencast Acquisition Corp

N/A

USD 0.48B
WALDW Waldencast Acquisition Corp

N/A

USD 0.37B
HNST Honest Company Inc

N/A

USD 0.25B
SKIN Beauty Health Co

N/A

USD 0.22B
RAY Raytech Holding Limited Ordina..

N/A

USD 0.07B
UG United-Guardian Inc

N/A

USD 0.04B

ETFs Containing CTCX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -65.09% 23% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.09% 23% F 7% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.02B 23% F 18% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector